UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 347

Sortiert nach

Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia

Psychiatry research, 2018-07, Vol.265, p.25-38

2018

Link zum Volltext

Verfügbarkeit prüfen

Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment

Nature communications, 2018-06, Vol.9 (1), p.2265-11, Article 2265

2018

Link zum Volltext

Verfügbarkeit prüfen

Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis

Schizophrenia research, 2021-02, Vol.228, p.60-73

2021

Link zum Volltext

Verfügbarkeit prüfen

Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342–3p

Cancer letters, 2020-05, Vol.477 (C), p.107-121

2020

Link zum Volltext

Verfügbarkeit prüfen

Loss of Dysbindin Implicates Synaptic Vesicle Replenishment Dysregulation as a Potential Pathogenic Mechanism in Schizophrenia

Neuroscience, 2021-01, Vol.452, p.138-152

2021

Link zum Volltext

Verfügbarkeit prüfen

Markers of copper transport in the cingulum bundle in schizophrenia

Schizophrenia research, 2021-02, Vol.228, p.124-133

2021

Link zum Volltext

Verfügbarkeit prüfen

Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice—Potential Link to Cognitive Impairment in Schizophrenia

Molecular neurobiology, 2017-04, Vol.54 (3), p.1699-1709

2017

Link zum Volltext

Verfügbarkeit prüfen

Dysbindin-1 Involvement in the Etiology of Schizophrenia

International journal of molecular sciences, 2017-09, Vol.18 (10), p.2044

2017

Link zum Volltext

Verfügbarkeit prüfen

Animal models of schizophrenia

British journal of pharmacology, 2011-10, Vol.164 (4), p.1162-1194

2011

Link zum Volltext

Verfügbarkeit prüfen

Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story

The world journal of biological psychiatry, 2020-01, Vol.21 (1), p.13-28

2020

Link zum Volltext

Verfügbarkeit prüfen

Cortical copper transporter expression in schizophrenia: interactions of risk gene dysbindin-1

Journal of Neural Transmission, 2021-05, Vol.128 (5), p.701-709

2021

Link zum Volltext

Verfügbarkeit prüfen

Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma

Scientific reports, 2022-01, Vol.12 (1), p.211-211, Article 211

2022

Link zum Volltext

Verfügbarkeit prüfen

Schizophrenia‐associated gene dysbindin‐1 and tardive dyskinesia

Drug development research, 2021-08, Vol.82 (5), p.678-684

2021

Link zum Volltext

Verfügbarkeit prüfen

Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice

Brain research bulletin, 2020-11, Vol.164, p.339-349

2020

Link zum Volltext

Verfügbarkeit prüfen

The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans

Molecular psychiatry, 2021-04, Vol.26 (4), p.1272-1285

2021

Link zum Volltext

Verfügbarkeit prüfen

Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness

Molecular psychiatry, 2019-07, Vol.24 (7), p.936-951

2019

Link zum Volltext

Verfügbarkeit prüfen

Hermansky-Pudlak syndrome with early onset inflammatory bowel disease due to loss of dysbindin expression

European journal of medical genetics, 2023-07, Vol.66 (7), p.104786-104786, Article 104786

2023

Link zum Volltext

Verfügbarkeit prüfen

Loss of dysbindin-1 in excitatory neurons in mice impacts NMDAR-dependent behaviors, neuronal morphology and synaptic transmission in the ventral hippocampus

Scientific reports, 2024-07, Vol.14 (1), p.15239-17, Article 15239

2024

Link zum Volltext

Verfügbarkeit prüfen

Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects

Schizophrenia bulletin, 2010-03, Vol.36 (2), p.246-270

van den Buuse, Maarten

2010

Link zum Volltext

Verfügbarkeit prüfen

Dysbindin-1 regulates mitochondrial fission and gamma oscillations

Molecular psychiatry, 2021-09, Vol.26 (9), p.4633-4651

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of fingolimod administration in a genetic model of cognitive deficits

Journal of neuroscience research, 2017-05, Vol.95 (5), p.1174-1181

2017

Link zum Volltext

Verfügbarkeit prüfen

Vaccinia-related kinase 2 variants differentially affect breast cancer growth by regulating kinase activity

Oncology research, 2024-01, Vol.32 (2), p.421-432

2024

Link zum Volltext

Verfügbarkeit prüfen

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Molecular psychiatry, 2005-01, Vol.10 (1), p.40-68

2005

Link zum Volltext

Verfügbarkeit prüfen

BLOC-1 is required for selective membrane protein trafficking from endosomes to primary cilia

The Journal of cell biology, 2017-07, Vol.216 (7), p.2131-2150

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 347

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(330)
Mit Volltextzugriff
(318)

Publikationsform

Artikel
(345)
Buchkapitel
(2)

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Dysbindin
(322)
Science & Technology
(304)
Life Sciences & Biomedicine
(285)
Humans
(259)
Schizophrenia
(233)
Dystrophin-Associated Proteins
(232)
Carrier Proteins - Genetics
(217)
Schizophrenia - Genetics
(182)
Animals
(138)
Neurosciences
(138)
Psychiatry
(134)
Male
(133)
Neurosciences & Neurology
(131)
Biological And Medical Sciences
(108)
Female
(108)
Medical Sciences
(98)
Mice
(93)
Psychology. Psychoanalysis. Psychiatry
(90)
Psychopathology. Psychiatry
(89)
Adult And Adolescent Clinical Studies
(85)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia

Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment

Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis

Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342–3p

Loss of Dysbindin Implicates Synaptic Vesicle Replenishment Dysregulation as a Potential Pathogenic Mechanism in Schizophrenia

Markers of copper transport in the cingulum bundle in schizophrenia

Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice—Potential Link to Cognitive Impairment in Schizophrenia

Dysbindin-1 Involvement in the Etiology of Schizophrenia

Animal models of schizophrenia

Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story

Cortical copper transporter expression in schizophrenia: interactions of risk gene dysbindin-1

Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma

Schizophrenia‐associated gene dysbindin‐1 and tardive dyskinesia

Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice

The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans

Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness

Hermansky-Pudlak syndrome with early onset inflammatory bowel disease due to loss of dysbindin expression

Loss of dysbindin-1 in excitatory neurons in mice impacts NMDAR-dependent behaviors, neuronal morphology and synaptic transmission in the ventral hippocampus

Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia

Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects

Dysbindin-1 regulates mitochondrial fission and gamma oscillations

Effects of fingolimod administration in a genetic model of cognitive deficits

Vaccinia-related kinase 2 variants differentially affect breast cancer growth by regulating kinase activity

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

BLOC-1 is required for selective membrane protein trafficking from endosomes to primary cilia

Suchergebnisse filtern